BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7262834)

  • 1. The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins.
    Baughman S; Felten SY; Lee W; Moore SA; O'Connor BL; Peterson RG
    Horm Metab Res; 1981 Jun; 13(6):331-5. PubMed ID: 7262834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of peripheral nerve myelin in experimental diabetes.
    Spritz N; Singh H; Marinan B
    J Clin Invest; 1975 May; 55(5):1049-56. PubMed ID: 123535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered metabolic incorporation of fucose and leucine into PNS myelin of 25-week-old diabetic (C57BL/Ks [db/db]) mice: effects of untreated diabetes on nerve metabolism.
    Chez MG; Peterson RG
    Neurochem Res; 1983 Apr; 8(4):465-72. PubMed ID: 6888648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of fucose/leucine incorporation into PNS myelin by isoniazid neuropathy.
    Colip MP; Baughman S; Peterson RG
    J Neurobiol; 1981 Mar; 12(2):193-7. PubMed ID: 6260895
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of experimental diabetes on the incorporation of amino acids into protein in rat aorta.
    Arnqvist HJ; Dahlkvist HH
    Horm Metab Res; 1979 Jun; 11(6):384-8. PubMed ID: 468102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of fucose and leucine into PNS myelin proteins in nerves undergoing early Wallerian degeneration.
    Peterson RG; Baughman S; Scheidler DM
    Neurochem Res; 1981 Feb; 6(2):213-23. PubMed ID: 7242779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted hypotonic swelling of peripheral nerve myelin in streptozocin-induced diabetic rats.
    Kirschner DA; Eichberg J
    J Neurosci Res; 1994 Jun; 38(2):142-8. PubMed ID: 8078099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of myelin proteins and ultrastructural investigations in regenerating rat sciatic nerve.
    Alberghina M; Bernocchi G; Biggiogera M; Viola M; Karlsson JO; Manfredi-Romanini MG; Giuffrida AM
    J Neurosci Res; 1985; 13(4):551-62. PubMed ID: 2409294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral nerve biochemistry in diabetes.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():19-22. PubMed ID: 2421965
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of sciatic nerve neuropathy in diabetic and aged rats.
    Koura NH
    Folia Biol (Krakow); 2003; 51(3-4):213-8. PubMed ID: 15303377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alloxan diabetes and insulin on the rate of protein synthesis in the rat submandibular gland.
    Anderson LC; Shapiro BL
    Horm Metab Res; 1980 Feb; 12(2):47-50. PubMed ID: 6989729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation in vivo of radioisotopic precursors into seromucoid proteins in streptozotocin diabetic rats.
    Guzdek A; Noworytko J; Sarnecka-Keller M
    Horm Metab Res; 1981 Sep; 13(9):491-4. PubMed ID: 7298017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of peripheral neuropathy in streptozotocin-induced diabetes in rats].
    Cai F
    Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):86-9, 8. PubMed ID: 2527588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoradiographic studies on protein metabolism and histochemical demonstration of the brain zinc content in diabetes mellitus. 1. Comparison in experimental streptozotocin-induced diabetes].
    Gatzke HD; Wildmeister W
    Endokrinologie; 1979; 74(3):323-46. PubMed ID: 161876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts.
    Vlassara H; Brownlee M; Cerami A
    J Exp Med; 1984 Jul; 160(1):197-207. PubMed ID: 6736870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerative neuropathy in insulin-treated diabetic rats.
    Westfall SG; Felten DL; Mandelbaum JA; Moore SA; Peterson RG
    J Neurol Sci; 1983 Sep; 61(1):93-107. PubMed ID: 6355399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of peripheral nervous system myelin proteins in vitro.
    Smith ME
    J Neurochem; 1980 Nov; 35(5):1183-9. PubMed ID: 7452311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of entry P0 protein into peripheral nerve myelin.
    Rapaport RN; Benjamins JA
    J Neurochem; 1981 Jul; 37(1):164-71. PubMed ID: 7252501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.